According to the latest report from Citeab, on individual antibody trends, Agrisera's anti-RbcL | Rubisco large subunit, form I and form II antibody, available for researchers since 2003, is the most published anti-Rubisco antibody, currently on the market. Together with 18 other Agrisera antibodies, this antibody is included in the list of the first 10 000 most published antibodies in the world.